The difficult road to new vaccines for pertussis and serogroup B meningococcal disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The difficult road to new vaccines for pertussis and serogroup B meningococcal disease
Authors
Keywords
-
Journal
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
Volume 91, Issue 1, Pages 9-15
Publisher
Wiley
Online
2015-07-23
DOI
10.1002/jctb.4784
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Large Portion of Meningococcal Antigen Typing System-Negative Meningococcal Strains from Spain Is Killed by Sera from Adolescents and Infants Immunized with 4CMenB
- (2015) R. Abad et al. Clinical and Vaccine Immunology
- Pertussis vaccines and the challenge of inducing durable immunity
- (2015) Jason M Warfel et al. CURRENT OPINION IN IMMUNOLOGY
- Neisseria meningitidisserogroup B bivalent factor H binding protein vaccine
- (2015) Nathan James Brendish et al. Expert Review of Vaccines
- Binding of Complement Factor H to PorB3 and NspA Enhances Resistance of Neisseria meningitidis to Anti-Factor H Binding Protein Bactericidal Activity
- (2015) Serena Giuntini et al. INFECTION AND IMMUNITY
- Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012
- (2015) J. R. MacNeil et al. PEDIATRICS
- Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02Vin Elderly Adults
- (2014) Karlis Pauksens et al. Clinical and Vaccine Immunology
- Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development
- (2014) Carina Brehony et al. Clinical and Vaccine Immunology
- Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage
- (2014) S. W. Martin et al. CLINICAL INFECTIOUS DISEASES
- A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012-2013
- (2014) G. Dabrera et al. CLINICAL INFECTIOUS DISEASES
- The baboon model of pertussis: effective use and lessons for pertussis vaccines
- (2014) Jason M Warfel et al. Expert Review of Vaccines
- Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology
- (2014) Sarah L Sheridan et al. Expert Review of Vaccines
- Nonhuman Primate and Human Challenge Models of Pertussis
- (2014) T. J. Merkel et al. JOURNAL OF INFECTIOUS DISEASES
- Pertussis Vaccine Trials in the 1990s
- (2014) L. C. Lambert JOURNAL OF INFECTIOUS DISEASES
- Genomic Analysis of Isolates From the United Kingdom 2012 Pertussis Outbreak Reveals That Vaccine Antigen Genes Are Unusually Fast Evolving
- (2014) Katie L. Sealey et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
- (2014) Robert C Read et al. LANCET
- Winter is coming: vaccine negotiations should be concluded swiftly
- (2014) L. Glennie et al. BMJ-British Medical Journal
- Cost effectiveness has its place, but so does common sense
- (2014) R. Rappuoli et al. BMJ-British Medical Journal
- Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
- (2014) H. Christensen et al. BMJ-British Medical Journal
- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)
- (2014) Roman Prymula et al. Human Vaccines & Immunotherapeutics
- The Discovery and Development of a Novel Vaccine to Protect againstNeisseria meningitidisSerogroup B Disease
- (2014) Gary W Zlotnick et al. Human Vaccines & Immunotherapeutics
- Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
- (2013) M. D. Snape et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review
- (2013) G Amirthalingam et al. Eurosurveillance
- Development of a large scale human complement source for use in bacterial immunoassays
- (2013) Charlotte Brookes et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
- (2013) DM Daugla et al. LANCET
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
- (2013) Ulrich Vogel et al. LANCET INFECTIOUS DISEASES
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of meningococcal serogroup C vaccine programmes
- (2013) Ray Borrow et al. VACCINE
- Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
- (2013) Giacomo Frosi et al. VACCINE
- Developing vaccines in the era of genomics: a decade of reverse vaccinology
- (2012) K.L. Seib et al. CLINICAL MICROBIOLOGY AND INFECTION
- California Pertussis Epidemic, 2010
- (2012) Kathleen Winter et al. JOURNAL OF PEDIATRICS
- Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
- (2012) Ryan T Novak et al. LANCET INFECTIOUS DISEASES
- Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study
- (2012) Russell M Viner et al. LANCET NEUROLOGY
- Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps
- (2012) Marjolein van Gent et al. PLoS One
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens
- (2012) Davide Serruto et al. VACCINE
- A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial
- (2012) P.C. Richmond et al. VACCINE
- Bexsero
- (2012) Andrew R. Gorringe et al. Human Vaccines & Immunotherapeutics
- Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand
- (2011) Richard Arnold et al. VACCINE
- Antibody Response Patterns to Bordetella pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children with Pertussis
- (2010) J. D. Cherry et al. Clinical and Vaccine Immunology
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Review of Meningococcal Group B Vaccines
- (2010) Dan M. Granoff CLINICAL INFECTIOUS DISEASES
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults
- (2010) Bruce K. Brown et al. PLoS One
- Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans
- (2010) Davide Serruto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
- (2010) J. Donnelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
- (2009) Amanda C. Cohn et al. CLINICAL INFECTIOUS DISEASES
- Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
- (2009) Caroline L Trotter et al. Expert Review of Vaccines
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
- (2009) Muriel C. Schneider et al. NATURE
- Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
- (2009) Johan Holst et al. VACCINE
- Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
- (2009) Carl E. Frasch et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More